Search Results for "Reminder Sample Letter Prostate Cancer"

04:12 EDT 27th March 2015 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

Increase in PSA after prostate cancer surgery may not lead to metastasis in some men's lifetimes

Some prostate cancer patients whose prostate-specific antigen (PSA) levels increase after a radical prostatectomy may die of causes unrelated to prostate cancer before they are diagnosed with a prosta...

An increase in PSA after prostate cancer surgery may not lead to metastasis in their lifetime

Some prostate cancer patients whose prostate-specific antigen (PSA) levels increase after a radical prostatectomy may die of causes unrelated to prostate cancer before they are diagnosed with a prosta...

Prostate cancer: Predicting prostate biopsy results—PCA3 versus phi

Data comparing tests designed to predict the likelihood of finding significant prostate cancer on biopsy are limited. A comparison of two such tests—the Prostate Health Index (phi) and prostate canc...

Predicting prostate cancer: Nanotechnology shows promise for more accurate prostate cancer screening and prognosis

A study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments. The prostate-specific antigen (PSA) te...

Drug Combo SuppressesLate-Stage Prostate Cancer Growth

Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue University study finds....

RNA molecules found in urine, tissue that detect prostate cancer

Potential biomarkers may pave way to a more sensitive, specific, and non-invasive prostate cancer screening assay, according to a report. Today, prostate cancer is primarily detected and monitored by ...

New study findings help physicians and patients determine prostate cancer risk

(University of Utah Health Sciences) A discovery by researchers at Huntsman Cancer Institute shows that looking at whether a man's uncles and great-grandparents, among other second- and third-degree r...

Common prostate cancer treatment associated with decreased survival in older men

A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at Henry Ford Hospital.

Matching PubMed Articles

Prevention and early detection of prostate cancer.

Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to...

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations.

Few previous studies of metabolic aberrations and prostate cancer risk have taken into account the fact that men with metabolic aberrations have an increased risk of death from causes other than prost...

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure.

Prostate cancer is a highly heterogeneous disease and one of the leading causes of mortality in developed countries. Specific prognostic and predictive markers for prostate cancer patients are still l...

Genetic predisposition to prostate cancer: Update and future perspectives.

Prostate cancer is the second most frequent cancer in men worldwide and kills over 250,000 men worldwide every year. Prostate cancer is a heterogeneous disease at the clinical and the molecular level....

Prostate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection.

We investigate the effectiveness of prostate-specific antigen (PSA) screening for prostate cancer. We compare the characteristics of 2 sets of patients: (1) those in whom prostate cancer was detected ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement